72 related articles for article (PubMed ID: 38491129)
1. Synthetic MRI and diffusion-weighted imaging for differentiating nasopharyngeal lymphoma from nasopharyngeal carcinoma: combination with morphological features.
Zhang H; Hu L; Qin F; Chang J; Zhong Y; Dou W; Hu S; Wang P
Br J Radiol; 2024 Jun; 97(1159):1278-1285. PubMed ID: 38733577
[TBL] [Abstract][Full Text] [Related]
2. Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors.
Li Y; Lin L; Zhang Y; Ren C; Zhang W; Cheng J
Front Oncol; 2024; 14():1402628. PubMed ID: 38903728
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the added value of synthetic magnetic resonance imaging in predicting sentinel lymph node status in breast cancer.
Yang X; Lu Z; Tan X; Shao L; Shi J; Dou W; Sun Z
Quant Imaging Med Surg; 2024 Jun; 14(6):3789-3802. PubMed ID: 38846281
[TBL] [Abstract][Full Text] [Related]
4. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive identification of HER2-zero, -low, or -overexpressing breast cancers: Multiparametric MRI-based quantitative characterization in predicting HER2-low status of breast cancer.
Zhan T; Dai J; Li Y
Eur J Radiol; 2024 Jun; 177():111573. PubMed ID: 38905803
[TBL] [Abstract][Full Text] [Related]
6. Amide Proton Transfer-Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer.
Kong L; Li H; Cai Q; Cao W; Chen Y; Weng B; Li M; Zhang M; Qian L; Guo Y; Ling J; Wen Z; Wang H
J Magn Reson Imaging; 2024 Jun; ():. PubMed ID: 38822655
[TBL] [Abstract][Full Text] [Related]
7. Editorial for "Amide Proton Transfer-Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer".
Li J
J Magn Reson Imaging; 2024 Jun; ():. PubMed ID: 38868924
[No Abstract] [Full Text] [Related]
8. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
Eur Radiol; 2024 Mar; ():. PubMed ID: 38491129
[TBL] [Abstract][Full Text] [Related]
9. Synthetic MRI in differentiating benign from metastatic retropharyngeal lymph node: combination with diffusion-weighted imaging.
Wang P; Hu S; Wang X; Ge Y; Zhao J; Qiao H; Chang J; Dou W; Zhang H
Eur Radiol; 2023 Jan; 33(1):152-161. PubMed ID: 35951044
[TBL] [Abstract][Full Text] [Related]
10. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study.
Yang L; Wang L; Tan Y; Dan H; Xian P; Zhang Y; Tan Y; Lin M; Zhang J
Cancer Imaging; 2023 Jan; 23(1):3. PubMed ID: 36611191
[TBL] [Abstract][Full Text] [Related]
11. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of benign and malignant breast lesions using quantitative synthetic magnetic resonance imaging].
Zhang L; Zhao X; Yin X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):457-462. PubMed ID: 35527481
[TBL] [Abstract][Full Text] [Related]
13. The Value of Amide Proton Transfer MRI in the Diagnosis of Malignant and Benign Urinary Bladder Lesions: Comparison With Diffusion-Weighted Imaging.
Li JL; Xu Y; Xiang YS; Wu P; Shen AJ; Wang PJ; Wang F
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38174777
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
